Sirtuin 5-mediated desuccinylation of Slc25a4 inhibits osteoporosis by enhancing mitochondrial respiration

Abstract

Osteoporosis is a prevalent metabolic bone disorder that develops when osteoclast-mediated bone resorption chronically exceeds osteoblast-driven bone formation. The molecular pathways that govern osteogenic dysfunction and connect cellular metabolism to differentiation regulation remain poorly characterized. Here, we identify Sirtuin 5 (Sirt5) as a pivotal osteogenic regulator through bioinformatic screening and functional validation in Sirt5-knockout mice. Mechanistically, Sirt5 governs mitochondrial homeostasis by desuccinylating Solute Carrier Family 25 Member 4 (Slc25a4) at lysine 147 (K147), as demonstrated by quantitative succinylome profiling and site-directed mutagenesis. This site-specific desuccinylation triggers Slc25a4 degradation, attenuating mitochondrial oxidative stress and promoting osteoblast differentiation. Crucially, Slc25a4-K147 succinylation drives osteoporosis progression, while Sirt5-mediated desuccinylation at this site confers protection. Our work reveals the Sirt5-Slc25a4-K147 axis as a novel regulatory mechanism coupling mitochondrial metabolism to bone homeostasis, offering a therapeutic target for osteoporosis intervention.

References

[1] Lane NE. Epidemiology, etiology, and diagnosis of osteoporosis. Am. J. Obstet. Gynecol., 2006, 194: S3-S11

[2] Kanis JA, Johnell O, Oden A, Johansson H, McCloskey E. FRAX and the assessment of fracture probability in men and women from the UK. Osteoporos. Int., 2008, 19: 385-397

[3] Wu X, et al.. RANKL regulates Fas expression and Fas-mediated apoptosis in osteoclasts. J. Bone Miner. Res., 2005, 20: 107-116

[4] Kaur M, Nagpal M, Singh M. Osteoblast-n-osteoclast: making headway to osteoporosis treatment. Curr. Drug Targets, 2020, 21: 1640-1651

[5] Long F. Building strong bones: molecular regulation of the osteoblast lineage. Nat. Rev. Mol. Cell Biol., 2011, 13: 27-38

[6] Shen G, et al.. Foxf1 knockdown promotes BMSCs osteogenesis in part by activating the Wnt/β-catenin signalling pathway and prevents ovariectomy-induced bone loss.. EBioMedicine, 2020, 52: 102626

[7] Yoshida G, et al.. Degradation of the NOTCH intracellular domain by elevated autophagy in osteoblasts promotes osteoblast differentiation and alleviates osteoporosis. Autophagy, 2022, 18: 2323-2332

[8] Deng TT, et al.. Pharmacological and mechanistic aspects of quercetin in osteoporosis. Front. Pharm., 2024, 15 1338951

[9] Li Q, Gao Z, Chen Y, Guan MX. The role of mitochondria in osteogenic, adipogenic and chondrogenic differentiation of mesenchymal stem cells. Protein Cell, 2017, 8: 439-445

[10] Spinelli JB, Haigis MC. The multifaceted contributions of mitochondria to cellular metabolism. Nat. Cell Biol., 2018, 20: 745-754

[11] Suh J, et al.. Mitochondrial fragmentation and donut formation enhance mitochondrial secretion to promote osteogenesis. Cell Metab., 2023, 35: 345-360.e7

[12] Gao J, et al.. SIRT3/SOD2 maintains osteoblast differentiation and bone formation by regulating mitochondrial stress. Cell Death Differ., 2018, 25: 229-240

[13] Pacher P, Beckman JS, Liaudet L. Nitric oxide and peroxynitrite in health and disease. Physiol. Rev., 2007, 87: 315-424

[14] Madreiter-Sokolowski CT, Thomas C, Ristow M. Interrelation between ROS and Ca2+ in aging and age-related diseases.. Redox Biol., 2020, 36: 101678

[15] Schwer B, Verdin E. Conserved metabolic regulatory functions of sirtuins. Cell Metab., 2008, 7: 104-112

[16] Fiorentino F, Castiello C, Mai A, Rotili D. Therapeutic potential and activity modulation of the protein lysine deacylase sirtuin 5. J. Med. Chem., 2022, 65: 9580-9606

[17] Dölle C, Rack JG, Ziegler M. NAD and ADP-ribose metabolism in mitochondria. FEBS J., 2013, 280: 3530-3541

[18] van de Peppel J, et al.. Identification of three early phases of cell-fate determination during osteogenic and adipogenic differentiation by transcription factor dynamics.. Stem Cell Rep., 2017, 8: 947-960

[19] Vaz C, Bee Tee B, Yong D, Yi Lee Q, Tanavde V. Mesenchymal stromal cells derived from human embryonic stem cells, fetal limb and bone marrow share a common phenotype but are transcriptionally and biologically different. Stem Cell Discov., 2017, 7: 1-26

[20] Lekva T, et al.. The glucocorticoid-induced leucine zipper gene (GILZ) expression decreases after successful treatment of patients with endogenous Cushing’s syndrome and may play a role in glucocorticoid-induced osteoporosis. J. Clin. Endocrinol. Metab., 2010, 95: 246-255

[21] Shuai L, et al.. SIRT5 regulates brown adipocyte differentiation and browning of subcutaneous white adipose tissue. Diabetes, 2019, 68: 1449-1461

[22] Zorov DB, Juhaszova M, Sollott SJ. Mitochondrial reactive oxygen species (ROS) and ROS-induced ROS release. Physiol. Rev., 2014, 94: 909-950

[23] Deng S, et al.. Dexamethasone induces osteoblast apoptosis through ROS-PI3K/AKT/GSK3β signaling pathway. Biomed. Pharmacother., 2019, 110: 602-608

[24] Bueno NP, et al.. Enhancing osteoblast differentiation and bone repair: the priming effect of photobiomodulation on adipose stromal cells. J. Photochem. Photobiol. B, 2024, 260 113040

[25] Bauer TM, Murphy E. Role of mitochondrial calcium and the permeability transition pore in regulating cell death. Circ. Res., 2020, 126: 280-293

[26] He W, Newman JC, Wang MZ, Ho L, Verdin E. Mitochondrial sirtuins: regulators of protein acylation and metabolism.. Trends Endocrinol. Metab., 2012, 23: 467-476

[27] Nakagawa T, Lomb DJ, Haigis MC, Guarente L. SIRT5 deacetylates carbamoyl phosphate synthetase 1 and regulates the urea cycle. Cell, 2009, 137: 560-570

[28] Clémençon B, Babot M, Trézéguet V. The mitochondrial ADP/ATP carrier (SLC25 family): pathological implications of its dysfunction. Mol. Asp. Med., 2013, 34: 485-493

[29] El-Hattab AW, Craigen WJ, Scaglia F. Mitochondrial DNA maintenance defects.. Biochim. Biophys. Acta Mol. Basis Dis., 2017, 1863: 1539-1555

[30] Baechler BL, Bloemberg D, Quadrilatero J. Mitophagy regulates mitochondrial network signaling, oxidative stress, and apoptosis during myoblast differentiation.. Autophagy, 2019, 15: 1606-1619

[31] Tang X, et al.. Mitochondrial GSNOR alleviates cardiac dysfunction via ANT1 denitrosylation. Circ. Res., 2023, 133: 220-236

[32] Tosserams A, et al.. Two new cases of mitochondrial myopathy with exercise intolerance, hyperlactatemia and cardiomyopathy, caused by recessive SLC25A4 mutations. Mitochondrion, 2018, 39: 26-29

[33] Zhivodernikov IV, Kirichenko TV, Markina YV, Postnov AY, Markin AM. Molecular and cellular mechanisms of osteoporosis. Int. J. Mol. Sci., 2023, 24: 15772

[34] Kato TM, et al.. Ant1 mutant mice bridge the mitochondrial and serotonergic dysfunctions in bipolar disorder. Mol. Psychiatry, 2018, 23: 2039-2049

[35] Zhou T, et al.. Single-cell transcriptomics in MI identify Slc25a4 as a new modulator of mitochondrial malfunction and apoptosis-associated cardiomyocyte subcluster. Sci. Rep., 2024, 14 9274

Funding

National Natural Science Foundation of China (National Science Foundation of China)(82130027)

RIGHTS & PERMISSIONS

The Author(s)